BR vs OGEN · P/E 16, rev $6.89B vs rev $37.7K
Broadridge Financial Solutions Inc (BR) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the BR and OGEN stock pages for the full models.
Not investment advice.